Plasma glucagon-like peptide 1 and peptide YY levels are not altered in symptomatic fructose-sorbitol malabsorption

Scandinavian Journal of Gastroenterology

Volumn 43, Issue 10, 2008, Pages 1212-1218

  Valeur, Jørgen ^a   Øines, Eliann ^a   Helvik Morken, Mette ^a   Juul Holst, Jens ^b   Berstad, Arnold ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Breath tests; Fermentation; Food hypersensitivity; Fructose; Fructose intolerance; Glucagon like peptide 1; Irritable bowel syndrome; Peptide YY; Sorbitol; Volatile fatty acids

Indexed keywords

FRUCTOSE; GLUCAGON LIKE PEPTIDE 1; HYDROGEN; METHANE; PEPTIDE YY; SORBITOL;

ADULT; ARTICLE; CARBOHYDRATE INTOLERANCE; CLINICAL ARTICLE; CONTROLLED STUDY; EXCRETION; FEMALE; FOOD ALLERGY; HORMONE RELEASE; HUMAN; ILEUM; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROVOCATION TEST;

ADULT; BREATH TESTS; CASE-CONTROL STUDIES; FEMALE; FOOD HYPERSENSITIVITY; FRUCTOSE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; MALABSORPTION SYNDROMES; MALE; MIDDLE AGED; PEPTIDE YY; SORBITOL;

EID: 52149108083     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520802116448     Document Type: Article

References (42)

1. Born P. Carbohydrate malabsorption in patients with non-specific abdominal complaints. World J Gastroenterol 2007;13:5687-91.
2. Gibson PR, Newnham E, Barrett JS, Shepherd SJ, Muir JG. Review article: fructose malabsorption and the bigger picture. Aliment Pharmacol Ther 2007;25:349-63.
3. Wong D. Hereditary fructose intolerance. Mol Genet Metab 2005;85:165-7.
4. Van Citters GW, Lin HC. Ileal brake: neuropeptidergic control of intestinal transit. Curr Gastroenterol Rep 2006;8:367-73.
5. Gebhard B, Holst JJ, Biegelmayer C, Miholic J. Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome. Dig Dis Sci 2001;46:1915-23.
6. Yamamoto H, Mori T, Tsuchihashi H, Akabori H, Naito H, Tani T. A possible role of GLP-1 in the pathophysiology of early dumping syndrome. Dig Dis Sci 2005;50:2263-7.
7. Amori RE, Lau J, Pittas AG. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA 2007;298:194-206.
8. Feinle-Bisset C, Horowitz M. Dietary factors in functional dyspepsia. Neurogastroenterol Motil 2006;18:608-18.
9. Nakade Y, Tsukamoto K, Pappas TN, Takahashi T. Central glucagons-like peptide-1 delays solid gastric emptying via central CRF and peripheral sympathetic pathway in rats. Brain Res 2006;1111:117-21.
10. Nakade Y, Tsukamoto K, Iwa M, Pappas TN, Takahashi T. Glucagon-like peptide-1 accelerates colonic transit via central CRF and peripheral vagal pathways in conscious rats. Auton Neurosci 2007;131:50-6.
11. Piche T, des Varannes SB, Sacher-Huvelin S, Holst JJ, Cuber JC, Galmiche JP. Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. Gastroenterology 2003;124:894-902.
12. Van Der Veek PP, Biemond I, Masclee AA. Proximal and distal gut hormone secretion in irritable bowel syndrome. Scand J Gastroenterol 2006;41:170-7.
13. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804-11.
14. Simrén M, Stotzer PO, Sjovall H, Abrahamsson H, Bjornsson ES. Abnormal levels of neuropeptide Y and peptide YY in the colon in irritable bowel syndrome. Eur J Gastroenterol Hepatol 2003;15:55-62.
15. Fernandez-Banares F, Esteve-Pardo M, de Leon R, Humbert P, Cabre E, Llovet JM, et al. Sugar malabsorption in functional bowel disease: clinical implications. Am J Gastroenterol 1993;88:2044-50.
16. Arslan G, Kahrs GE, Lind R, Froyland L, Florvaag E, Berstad A. Patients with subjective food hypersensitivity: the value of analyzing intestinal permeability and inflammation markers in gut lavage fluid. Digestion 2004;70:26-35.
17. Levitt MD, Furne JK, Kuskowski M, Ruddy J. Stability of human methanogenic flora over 35 years and a review of insights obtained from breath methane measurements. Clin Gastroenterol Hepatol 2006;4:123-9.
18. Orskov C, Rabenhoj L, Wettergren A, Kofod H, Holst JJ. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 1994;43:535-9.
19. Vandvik PO, Aabakken L, Farup PG. Diagnosing irritable bowel syndrome: poor agreement between general practitioners and the Rome II criteria. Scand J Gastroenterol 2004;39:448-53.
20. Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003;98:1309-14.
21. Born P, Zech J, Lehn H, Classen M, Lorenz R. Colonic bacterial activity determines the symptoms in people with fructose-malabsorption. Hepatogastroenterology 1995;42:778-85.
22. Lembcke B, Folsch UR, Caspary WF, Ebert R, Creutzfeldt W. Influence of metronidazole on the breath hydrogen response and symptoms in acarbose-induced malabsorption of sucrose. Digestion 1982;25:186-93.
23. Morken MH, Berstad AE, Nysaeter G, Berstad A. Intestinal gas in plain abdominal radiographs does not correlate with symptoms after lactulose challenge. Eur J Gastroenterol Hepatol 2007;19:589-93.
24. Christl SU, Murgatroyd PR, Gibson GR, Cummings JH. Production, metabolism, and excretion of hydrogen in the large intestine. Gastroenterology 1992;102:1269-77.
25. Harder H, Serra J, Azpiroz F, Passos MC, Aguade S, Malagelada JR. Intestinal gas distribution determines abdominal symptoms. Gut 2003;52:1708-13.
26. Nucera G, Gabrielli M, Lupascu A, Lauritano EC, Santoliquido A, Cremonini F, et al. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2005;21:1391-5.
27. Morken MH, Nysaeter G, Strand EA, Hausken T, Berstad A. Lactulose breath test results in patients with persistent abdominal symptoms following Giardia lamblia infection. Scand J Gastroenterol 2008;43:141-5.
28. Posserud I, Stotzer PO, Bjornsson ES, Abrahamsson H, Simren M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007;56:802-8.
29. Jouet P, Sabate JM, Coffin B, Bouhnik Y, Lemann M, Jian R, et al. Sugar intolerance: origin and mechanisms of symptoms? Dig Dis Sci 2002;47:886-93.
30. Read NW. Diarrhoea: the failure of colonic salvage. Lancet 1982;2:481-3.
31. Symons P, Jones MP, Kellow JE. Symptom provocation in irritable bowel syndrome. Effects of differing doses of fructose-sorbitol. Scand J Gastroenterol 1992;27:940-4.
32. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001;81:1031-64.
33. Bourdu S, Dapoigny M, Chapuy E, Artigue F, Vasson MP, Dechelotte P, et al. Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats. Gastroenterology 2005;128:1996-2008.
34. Kien CL, Murray RD, Qualman SJ, Marcon M. Lactulose feeding in piglets: a model for persistent diarrhea and colitis induced by severe sugar malabsorption. Dig Dis Sci 1999;44:1476-84.
35. Hunter JO. Food allergy: or enterometabolic disorder? Lancet 1991;338:495-6.
36. Pimentel M, Lin HC, Enayati P, van den BB, Lee HR, Chen JH, et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am J Physiol Gastrointest Liver Physiol 2006;290:G1089-95.
37. Belson A, Shetty AK, Yorgin PD, Bujanover Y, Peled Y, Dar MH, et al. Colonic hydrogen elimination and methane production in infants with and without infantile colic syndrome. Dig Dis Sci 2003;48:1762-6.
38. Gibson GR, Cummings JH, Macfarlane GT, Allison C, Segal I, Vorster HH, et al. Alternative pathways for hydrogen disposal during fermentation in the human colon. Gut 1990;31:679-83.
39. Cherbut C, Ferrier L, Roze C, Anini Y, Blottiere H, Lecannu G, et al. Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat. Am J Physiol 1998;275:G1415-22.
40. Gee JM, Johnson IT. Dietary lactitol fermentation increases circulating peptide YY and glucagon-like peptide-1 in rats and humans. Nutrition 2005;21:1036-43.
41. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007;87:1409-39.
42. Cox HM, Peptide YY. A neuroendocrine neighbor of note. Peptides 2007;28:345-51.